Filter
482
Text search:
Pharmaceutical
Prices
Featured
Recommendations
39
New Publications
135
Language
Document type
No document type
238
Studies & Reports
132
Guidelines
51
Strategic & Response Plan
25
Manuals
17
Fact sheets
8
Situation Updates
6
Training Material
4
Resource Platforms
1
Countries / Regions
India
21
Global
21
Kenya
16
Uganda
14
Sierra Leone
9
Ghana
9
Ukraine
9
Liberia
8
Nigeria
8
Zambia
8
Tanzania
8
Ethiopia
7
Philippines
7
Syria
7
South Africa
7
Malawi
7
Zimbabwe
6
Nepal
6
Indonesia
6
Congo, Democratic Republic of
5
Bangladesh
5
Namibia
5
Western and Central Europe
5
Senegal
4
Cameroon
4
Rwanda
4
Botswana
4
Myanmar / Burma
4
Latin America and the Carribbean
4
Venezuela
4
Haiti
3
Mozambique
3
Lesotho
3
Africa
3
Eastern Europe
3
Pakistan
2
Germany
2
Papua New Guinea
2
Benin
2
Eswatini/ Swaziland
2
Albania
2
Burkina Faso
1
Mali
1
Niger
1
South Sudan
1
Jordan
1
Afghanistan
1
Lebanon
1
Egypt
1
Chad
1
Cambodia
1
China
1
Sudan
1
Central African Republic
1
North Macedonia
1
Libya
1
Sri Lanka
1
West and Central Africa
1
Middle East and North Africa
1
South–East Asia Region
1
Eastern Europe and Central Asia
1
Paraguay
1
Mongolia
1
Southern Africa
1
Laos
1
Bulgaria
1
Lithuania
1
Kyrgyzstan
1
Gabon
1
Turkmenistan
1
Authors & Publishers
Publication Years
Category
Countries
201
Clinical Guidelines
35
Public Health
17
Pharmacy & Technologies
13
Key Resources
12
Women & Child Health
9
Capacity Building
2
Toolboxes
Pharmacy
57
AMR
44
HIV
40
COVID-19
40
Mental Health
30
TB
14
Global Health Education
12
Health Financing Toolbox
12
Conflict
10
Planetary Health
8
NTDs
8
NCDs
7
Caregiver
5
Ebola & Marburg
4
Disability
3
Refugee
3
Polio
2
Malaria
2
Cholera
1
Natural Hazards
1
Rapid Response
1
2.0 Rapid Response
1
In recent years, high prices of pharmaceutical products have posed challenges in high- and low-income countries alike. In many instances, high prices
...
2nd edition - Published in 2003, the first WHO/HAI medicine prices manual Medicine Prices – A
New Approach to Measurement Draft for field-testing provides a draft methodology and tools to conduc
...
The National pharmaceutical policy aligns itself to the Government vision for development of the health sector, as defined in Vision 2020, the Millennium Development Goals and the Economic Development for Poverty Reduction Strategy and the National
...
Globally each year, millions of people suffer illness or lose their lives because the vaccines, medicines and diagnostic tests that they need are either unavailable or unaffordable – and this lack of access to medicine is acute in low- and middle-in-
come countries (LMICs). While the COVID-19 pan
...
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covi
...
The growing challenges for people in low and middle-income countries to access new medicines.
Analysis 58
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have hoarded vaccines, companies have also played a decisi
...
Prices people pay for medicines.
This field study to assess the pharmaceutical situation was undertaken in Ghana in May-June 2008 using a standardized methodology developed by the World Health Organization. The study assessed medicines availability and affor
...
Global UNIDO Project: Strengthening the local production of essential generic drugs in the least developed and developing countries
An Indicator-based Approach - This manual presents an indicator-based approach for rapidly assessing pharmaceutical management systems and programs. The manual contains a set of 46 indicators of performance, grouped under eight topics of
...
Guide for coordinators and data collectors - The WHO Operational Package for Assessing, Monitoring and Evaluating Country Pharmaceutical Situations is intended as a useful tool for researchers, policy-makers, planners and others who need to use stan
...
This article examines the activities of national and international actors in Pharmaceutical Services (PS) in Mozambique from 2007 to 2012, focusing on the public provision of HIV/Aids, malaria and tuberculosis medicines. It describes how PS function
...
2014-2020, Draft March 2014
